Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

HEART FAILURE

Transcatheter mitral valve repair in patients with CKD

A post hoc analysis of the COAPT trial suggests that transcatheter mitral valve repair for secondary mitral regurgitation is efficacious in patients with heart failure and chronic kidney disease. The intervention also reduced the risk of kidney failure, raising hypotheses regarding the mechanisms that link heart failure and loss of kidney function.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Beohar, N. et al. Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial. Eur. Heart J. ehac026 (2022).

  2. Stone, G. W. et al. Transcatheter mitral-valve repair in patients with heart failure. N. Engl. J. Med. 379, 2307–2318 (2018).

    Article  Google Scholar 

  3. Obadia, J.-F. et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N. Engl. J. Med. 379, 2297–2306 (2018).

    Article  Google Scholar 

  4. Sawalha, K. et al. Impact of chronic kidney disease on in-hospital outcomes and readmission rate after edge-to-edge transcatheter mitral valve repair. Catheter. Cardiovasc. Interv. 97, E569–E579 (2021).

    Article  Google Scholar 

  5. Dave, P. et al. The effect of transcatheter mitral valve repair on short-term mortality in patients with chronic kidney disease — a systematic review and meta-analysis. Cardiovasc. Revasc. Med. 30, 78–84 (2021).

    Article  Google Scholar 

  6. Konstantinidis, I. et al. Representation of patients with kidney disease in trials of cardiovascular interventions: an updated systematic review. JAMA Intern. Med. 176, 121–124 (2016).

    Article  Google Scholar 

  7. Kaneko, H., Neuss, M., Schau, T., Weissenborn, J. & Butter, C. Interaction between renal function and percutaneous edge-to-edge mitral valve repair using MitraClip. J. Cardiol. 69, 476–482 (2017).

    Article  Google Scholar 

  8. Kubo, S. et al. Impact of forward stroke volume response on clinical and structural outcomes after percutaneous mitral valve repair with MitraClip. Circ. Cardiovasc. Interv. 10, e004909 (2017).

    Article  Google Scholar 

  9. Wang, A. et al. Evaluation of renal function before and after percutaneous mitral valve repair. Circ. Cardiovasc. Interv. 8, e001349 (2015).

    Article  Google Scholar 

  10. Rassaf, T. et al. Influence of percutaneous mitral valve repair using the MitraClip® system on renal function in patients with severe mitral regurgitation. Catheter. Cardiovasc. Interv. 85, 899–903 (2015).

    Article  Google Scholar 

Download references

Acknowledgements

W.M. receives funding support from KL2 TR002545-04.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark J. Sarnak.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

McCallum, W., Sarnak, M.J. Transcatheter mitral valve repair in patients with CKD. Nat Rev Nephrol (2022). https://doi.org/10.1038/s41581-022-00583-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41581-022-00583-y

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing